TRADES
Latest Trades
2087
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 7 Sep 2021 Buy NVTA INVITAE CORP 261,144 0.0900
ARKG 7 Sep 2021 Sell MCRB SERES THERAPEUTICS INC 900 0.0000
ARKG 7 Sep 2021 Sell DRNA DICERNA PHARMACEUTICALS INC 152,759 0.0400
ARKG 7 Sep 2021 Buy CRSP CRISPR THERAPEUTICS AG 23,000 0.0300
ARKG 7 Sep 2021 Sell CRBU CARIBOU BIOSCIENCES INC 229,324 0.0800
ARKG 7 Sep 2021 Sell CLLS CELLECTIS SA 3,230 0.0000
ARKG 7 Sep 2021 Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 192,885 0.0900
ARKG 3 Sep 2021 Buy RPTX REPARE THERAPEUTICS INC 43,769 0.0200
ARKG 3 Sep 2021 Sell RHHBY ROCHE HOLDING AG 225,794 0.1300
ARKG 3 Sep 2021 Sell PSTI PLURISTEM THERAPEUTICS INC 21,208 0.0000
ARKG 3 Sep 2021 Buy PSNL PERSONALIS INC 11,524 0.0000
ARKG 3 Sep 2021 Buy PFE PFIZER INC 84,604 0.0500
ARKG 3 Sep 2021 Buy NVTA INVITAE CORP 19,564 0.0100
ARKG 3 Sep 2021 Sell MCRB SERES THERAPEUTICS INC 19,400 0.0000
ARKG 3 Sep 2021 Buy FATE FATE THERAPEUTICS INC 74,850 0.0600
ARKG 3 Sep 2021 Sell CLLS CELLECTIS SA 4,834 0.0000
ARKG 3 Sep 2021 Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 2,133 0.0000
ARKG 2 Sep 2021 Buy VEEV VEEVA SYSTEMS INC 57,616 0.2100
ARKG 2 Sep 2021 Sell SEER SEER INC 202 0.0000
ARKG 2 Sep 2021 Sell RHHBY ROCHE HOLDING AG 189,700 0.1100
ARKG 2 Sep 2021 Sell PSTI PLURISTEM THERAPEUTICS INC 20,154 0.0000
ARKG 2 Sep 2021 Buy PSNL PERSONALIS INC 21,034 0.0100
ARKG 2 Sep 2021 Buy PFE PFIZER INC 178,926 0.1000
ARKG 2 Sep 2021 Buy NVTA INVITAE CORP 17,243 0.0100
ARKG 2 Sep 2021 Sell MCRB SERES THERAPEUTICS INC 383,560 0.0300
ARKG 2 Sep 2021 Sell CLLS CELLECTIS SA 30,229 0.0100
ARKG 1 Sep 2021 Sell SEER SEER INC 3,702 0.0017
ARKG 1 Sep 2021 Buy RPTX REPARE THERAPEUTICS INC 3,200 0.0013
ARKG 1 Sep 2021 Sell RHHBY ROCHE HOLDING AG 426,800 0.2511
ARKG 1 Sep 2021 Sell PSTI PLURISTEM THERAPEUTICS INC 19,873 0.0007
ARKG 1 Sep 2021 Buy PSNL PERSONALIS INC 3,781 0.0010
ARKG 1 Sep 2021 Buy PFE PFIZER INC 382,231 0.2051
ARKG 1 Sep 2021 Buy NVTA INVITAE CORP 12,514 0.0044
ARKG 1 Sep 2021 Sell NVS NOVARTIS AG 32,322 0.0352
ARKG 1 Sep 2021 Sell MCRB SERES THERAPEUTICS INC 682,519 0.0517
ARKG 1 Sep 2021 Sell CLLS CELLECTIS SA 21,200 0.0037
ARKG 1 Sep 2021 Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 800 0.0003
ARKG 31 Aug 2021 Buy RPTX REPARE THERAPEUTICS INC 52,716 0.0210
ARKG 31 Aug 2021 Sell RHHBY ROCHE HOLDING AG 229,100 0.1372
ARKG 31 Aug 2021 Sell PSTI PLURISTEM THERAPEUTICS INC 13,833 0.0005
ARKG 31 Aug 2021 Buy PSNL PERSONALIS INC 19,246 0.0048
ARKG 31 Aug 2021 Buy PFE PFIZER INC 86,248 0.0480
ARKG 31 Aug 2021 Buy NVTA INVITAE CORP 20,319 0.0070
ARKG 31 Aug 2021 Sell NVS NOVARTIS AG 142,994 0.1572
ARKG 31 Aug 2021 Buy FATE FATE THERAPEUTICS INC 62,266 0.0534
ARKG 31 Aug 2021 Sell CLLS CELLECTIS SA 20,248 0.0035
ARKG 31 Aug 2021 Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 5,886 0.0025
ARKG 30 Aug 2021 Buy RPTX REPARE THERAPEUTICS INC 816 0.0003
ARKG 30 Aug 2021 Sell RHHBY ROCHE HOLDING AG 78,900 0.0467
ARKG 30 Aug 2021 Buy QSI QUANTUM-SI INC 163,652 0.0185
ARKG 30 Aug 2021 Sell PSTI PLURISTEM THERAPEUTICS INC 10,518 0.0004
ARKG 30 Aug 2021 Buy PSNL PERSONALIS INC 34,599 0.0086
ARKG 30 Aug 2021 Buy PFE PFIZER INC 91,400 0.0504
ARKG 30 Aug 2021 Buy NVTA INVITAE CORP 113,734 0.0392
ARKG 30 Aug 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 240,000 0.0285
ARKG 30 Aug 2021 Sell CLLS CELLECTIS SA 7,300 0.0012
ARKG 30 Aug 2021 Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 20,540 0.0088
ARKG 27 Aug 2021 Buy RPTX REPARE THERAPEUTICS INC 7,501 0.0030
ARKG 27 Aug 2021 Sell RHHBY ROCHE HOLDING AG 202,400 0.1236
ARKG 27 Aug 2021 Buy QSI QUANTUM-SI INC 1,818 0.0002
ARKG 27 Aug 2021 Sell PSTI PLURISTEM THERAPEUTICS INC 36,393 0.0013
ARKG 27 Aug 2021 Buy PSNL PERSONALIS INC 5,444 0.0013
ARKG 27 Aug 2021 Buy PFE PFIZER INC 351,289 0.2019
ARKG 27 Aug 2021 Sell MCRB SERES THERAPEUTICS INC 707,095 0.0539
ARKG 27 Aug 2021 Buy FATE FATE THERAPEUTICS INC 57,841 0.0509
ARKG 27 Aug 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 49,500 0.0060
ARKG 27 Aug 2021 Sell CLLS CELLECTIS SA 4,911 0.0009
ARKG 27 Aug 2021 Sell BMY BRISTOL-MYERS SQUIBB CO 90,757 0.0741
ARKG 27 Aug 2021 Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 1,000 0.0004
ARKG 26 Aug 2021 Sell SEER SEER INC 20,000 0.0089
ARKG 26 Aug 2021 Buy RPTX REPARE THERAPEUTICS INC 2,468 0.0010
ARKG 26 Aug 2021 Sell RHHBY ROCHE HOLDING AG 32,600 0.0196
ARKG 26 Aug 2021 Buy QSI QUANTUM-SI INC 34,201 0.0037
ARKG 26 Aug 2021 Sell PSTI PLURISTEM THERAPEUTICS INC 15,505 0.0006
ARKG 26 Aug 2021 Buy PSNL PERSONALIS INC 40,468 0.0094
ARKG 26 Aug 2021 Buy PFE PFIZER INC 173,579 0.1001
ARKG 26 Aug 2021 Sell MCRB SERES THERAPEUTICS INC 400 0.0000
ARKG 26 Aug 2021 Buy MASS 908 DEVICES INC 25,000 0.0101
ARKG 26 Aug 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 1,696 0.0002
ARKG 26 Aug 2021 Buy CMIIU CM LIFE SCIENCES II INC 25,000 0.0032
ARKG 26 Aug 2021 Sell BMY BRISTOL-MYERS SQUIBB CO 29,000 0.0236
ARKG 26 Aug 2021 Buy BEAM BEAM THERAPEUTICS INC 17,033 0.0207
ARKG 26 Aug 2021 Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 62,252 0.0254
ARKG 25 Aug 2021 Sell SEER SEER INC 152,557 0.0649
ARKG 25 Aug 2021 Sell RHHBY ROCHE HOLDING AG 66,000 0.0394
ARKG 25 Aug 2021 Buy QSI QUANTUM-SI INC 117,584 0.0128
ARKG 25 Aug 2021 Sell PSTI PLURISTEM THERAPEUTICS INC 16,223 0.0006
ARKG 25 Aug 2021 Buy PSNL PERSONALIS INC 43,612 0.0103
ARKG 25 Aug 2021 Buy PFE PFIZER INC 170,809 0.0987
ARKG 25 Aug 2021 Buy MASS 908 DEVICES INC 11,300 0.0047
ARKG 25 Aug 2021 Buy DYNS DYNAMICS SPECIAL PURPOSE CORP 3 0.0000
ARKG 25 Aug 2021 Buy CMIIU CM LIFE SCIENCES II INC 18,100 0.0023
ARKG 25 Aug 2021 Sell BMY BRISTOL-MYERS SQUIBB CO 114,400 0.0937
ARKG 25 Aug 2021 Buy ADPT ADAPTIVE BIOTECHNOLOGIES CORP 30,596 0.0126
ARKG 24 Aug 2021 Sell SEER SEER INC 82,789 0.0358
ARKG 24 Aug 2021 Buy RPTX REPARE THERAPEUTICS INC 229 0.0001
ARKG 24 Aug 2021 Sell RHHBY ROCHE HOLDING AG 226,200 0.1389
ARKG 24 Aug 2021 Buy QSI QUANTUM-SI INC 90,017 0.0095
ARKG 24 Aug 2021 Sell PSTI PLURISTEM THERAPEUTICS INC 48,386 0.0018
ARKG 24 Aug 2021 Buy PSNL PERSONALIS INC 4,500 0.0010
Latest Blogs
Is Cathie Wood's winning streak coming to an end? In the third quarter, Ark Invest ETFs underperformed a broader market

Even while other actively managed funds and fund managers battled to recover from the COVID-19-induced slowdown, Cathie Wood's Ark Invest had a spectacular year in 2020. Wood was dubbed the "Midas Touch" after her fund's flagship ARK Innovation ETF ARKK +0.77% (Get Free Alerts for ARKK) returned a whopping 153 percent, outperforming the S& P 500 Index's 16.3 percent gain.

Ark Experiences a Post-COVID-19 Complication: By 2021, Ark's performance had become more mixed. The Ark Innovation ETF dropped 3.7 percent in the first quarter before rebounding with a 9 percent gain in the second.

According to Ark's third-quarter performance report, all of its actively managed funds and its two self-indexed ETFs underperformed the market.

The performance of each Ark ETF in the third quarter is as follows:

 

ETFs that are actively traded

ETF: Ark Innovation: (-15.5 percent )

The Ark Autonomous Technology & Robotics ETF (ARKQ) is an exchange-traded fund that invests in autonomous technology and robotics (-9.5 percent )

The Ark Next Generation Internet ETF (ARKW) is an exchange-traded fund that invests in the next generation of the internet (-9.9 percent )

ETF for the Ark Genomic Revolution (ARKG): (-19.3 percent )

ARK Fintech Innovation ETF ARKF +0.06%: ARK Fintech Innovation ETF ARKF +0.06%: ARK Fintech Innovation ETF ARK (-8.7 percent )

ARK Space Exploration & Innovation ETF (ARKX): Ark ETF Trust: (-6.6 percent )

ETFs that track indices

The ETF for 3D Printing (PRNT): (-10 percent )

The Ark Israel Innovation Technology ETF (IZRL) is a mutual fund that invests in Israel's innovative technology (-8.3 percent )

When compared to the more significant market performance, the low showing is exemplified. The S& P 500 Index rose 2.5 percent in the third quarter, while the Nasdaq Composite Index rose 5.1 percent.

Consumer and investor confidence is being harmed by macro headwinds, according to Wood's quarterly report. Fears of an economic slowdown arose due to a spike in the delta strain of the coronavirus, supply chain difficulties, and a Chinese government crackdown, she noted.

Ark feels that inflation fears are exaggerated and that the chances of deflation are more plausible.

Will Bitcoin Be Banned In The United States Like Gold Was? Cathie Wood and Ark Invest weigh in.

 

Tesla Aids In Weakness Mitigation: Wood is a self-proclaimed Tesla, Inc. TSLA +3.26 percent bull. With over 10% stakes in each, Tesla is part of the ARK Innovation ETF, the Ark Innovation ETF, and the Ark Innovation ETF.

In the third quarter, the electric vehicle behemoth topped the list of contributors to the returns of each of these ETFs.

Ark Invest sold approximately $605 million of Tesla stock in September alone, taking advantage of the EV maker's third-quarter rally.

Tesla's sales have continued far into October.

Energy and financial services are the most likely to be disrupted by innovation. The power and financial services sectors have benefited the most from the shift toward cyclical in the last nine to 12 months, according to Ark. These two industries, according to the firm, will be the most disrupted by innovation during the next five years.

"Autonomous electric vehicles and digital wallets, including cryptocurrencies and the decentralized financial services (DeFi) associated more broadly with blockchain technologies, will, in ARK's opinion, significantly disrupt and disintermediate both Energy and Financial Services over the next five years."

 

Cathie Wood, the founder of Ark Invest, did not purchase the first Bitcoin futures ETF.

According to Business Insider, Ark Invest founder and CEO Cathie Wood did not invest in the ProShares Bitcoin Strategy exchange-traded fund (ETF) on its first day.

Wood had this to say regarding the ETF's debut:

"We did not [invest]," says the narrator. We're taking a close look at this [...] there are specific tax implications we'd like to learn more about in terms of contango versus more traditional backwardation."

When the future price is greater than the current price, the ETF is in contango. In a negative trend, backwardation occurs when the forward price of a futures contract is lower than the spot price.

In June, wood's Ark Invest teamed up with 21 Shares to file for its Bitcoin (BTC) ETF. When it comes to investing in cryptocurrencies, she is also no stranger to the stock market.

Ark Investment Management, one of her funds, has been permitted to invest in Canada's Bitcoin ETF, the Ark Next Generation ETF. Grayscale Bitcoin Trust (GBTC) has 8.3 million shares, with Bitcoin and Ether (ETH) accounting for a significant portion of Ark Invest's portfolio.

Ark Invest also added Coinbase stock to three of its ETFs in the spring, including the Ark Innovation ETF (ARKK), the Ark Next Generation Internet ETF (ARKW), and the Ark Fintech Innovation ETF (ARKF).

Wood stated that she is on the lookout for the next FAANG investment that will benefit her investors. FAANG is an abbreviation for the five largest American technology companies: Facebook, Amazon, Apple, Netflix, and Google. Jim Cramer first invented the phrase "FAANG" in 2013.

On its first day of trading, the Bitcoin Strategy ETF recorded the highest natural volume of any ETF and the second-highest overall volume.

 

Cathie Wood's Ark Invest is leaving Wall Street and relocating to Florida

Ark Investment Management said on Wednesday that it is permanently closing its New York office and relocating to St. Petersburg, Florida.

In 2020, Wood's flagship Ark Innovation exchange-traded fund soared over 150 percent, making her a Wall Street sensation.

Wood is unique in that she focuses solely on the technology industry. So it's probably unsurprising that she's quitting Wall Street.

Ark expects the move to "advance its business as it scales and continues to alter the asset management market," as well as "improve collaboration between and across the communities focused on innovation," according to the company.

"Ark isn't your typical Wall Street asset management firm, and we're excited to continue to break the mold by relocating to St. Petersburg, a city that values technology, research, and creativity," Wood added.

Jana Haines, Ark's strategy chief, said the area's "vibrant and diversified talent base" and the success of public-private partnerships centered on innovation encouraged the company.

This year hasn't been as good to Wood as the previous one. Despite a booming tech market, with the Nasdaq up more than 14 percent so far in 2021, the Innovation ETF is down 3.5 percent coming into the fourth quarter.